Biotech Values

[mcbio]

GILD - 16/24-week P3 GT1/GT3 study of sofosbuvir+riba

(H/t to @lomu_j for this find. Does this imply that 12 weeks of treatment will not be sufficient? Did GILD have some later relapsers previously? If so, doesn't this bode well for the other HCV players, namely those that have a chance to ultimately show that their combo can do the job in 12 weeks?)

http://clinicaltrials.gov/ct2/show/NCT01896193